Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Kleangas Energy Technologies Inc (EM) KGET

Healthcare Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic Cannabis
CaliPharms, Inc. engages in the medicinal Cannabis Industry in the United States. It focuses on the THC and CBD beverage industry. The company was formerly known as Kleangas Energy Technologies, Inc. and changed its name to CaliPharms, Inc. in January, 2017. CaliPharms, Inc. is based in Temecula, California.


EXPM:KGET - Post by User

Kleangas Energy Technologies Inc (EM)
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(60)
•••
  • bobismydadX
Post by bobismydadon Sep 14, 2020 12:52pm
92 Views
Post# 31553272

need better management

need better managementand cheaper diggs (HQ)


3175 Temecula Parkway, Suite A 8019, Temecula, CA, US, 92592
Telephone
+1 949 800-6645

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities